Collegium Pharmaceutical
COLL
138 hedge funds and large institutions have $649M invested in Collegium Pharmaceutical in 2019 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 40 increasing their positions, 41 reducing their positions, and 21 closing their positions.
433% more call options, than puts
Call options by funds: $1.26M | Put options by funds: $237K
100% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 21
88% more capital invested
Capital invested by funds: $345M → $649M (+$304M)
18% more funds holding
Funds holding: 117 → 138 (+21)
4.26% more ownership
Funds ownership: 89.72% → 93.98% (+4.3%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 41
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$13M |
| 2 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$12.7M |
| 3 |
Renaissance Technologies
New York
|
+$8.42M |
| 4 |
PA
Perceptive Advisors
New York
|
+$7.02M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$3.72M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
-$16.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$11.5M |
| 3 |
Prudential Financial
Newark,
New Jersey
|
-$4.18M |
| 4 |
SAM
Silvercrest Asset Management
New York
|
-$3.2M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$2.65M |
COLL Hedge Fund Activity: Q4 2019 in Review
138 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q4 2019, worth a combined $649M — up 88% from $345M a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new COLL positions and 21 closed out — a net gain of 21 holders — while 40 added to existing stakes and 41 trimmed.
The largest buyer was Emerald Advisers, opening a new position worth an estimated $13M. The largest seller was TPG Group Holdings (SBS) Advisors, exiting entirely with an estimated $16.5M sold.
- 138 institutional investors held Collegium Pharmaceutical (COLL) as of Q4 2019, up from 117 in Q3 2019.
- Funds reported $649M of Collegium Pharmaceutical stock for Q4 2019, up 88% quarter-over-quarter.
- 42 funds opened new Collegium Pharmaceutical positions in Q4 2019 and 21 closed out, a net change of +21 holders.
- The largest Collegium Pharmaceutical buyer in Q4 2019 was Emerald Advisers, an estimated $13M added.
- The largest Collegium Pharmaceutical seller in Q4 2019 was TPG Group Holdings (SBS) Advisors, an estimated $16.5M sold.
Based on aggregated 13F filings for Q4 2019.